SCHEMBL20233003

SCHEMBL20233003

CC(C)CC1CCN(C(=O)CCO)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
TACR3 P29371 1/20 0.36
GNAI3 P08754 2/20 0.35
GNAO1 P09471 2/20 0.35
GNAI1 P63096 2/20 0.35
SMYD3 Q9H7B4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 1/20 0.35
DPP4 P27487 2/20 0.34
DPP8 Q6V1X1 2/20 0.34
DPP9 Q86TI2 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12448272 0.87 DPP4 (0.39) NPC1MEN1KMT2APOLBMAPT
SCHEMBL12876369 0.83 EPHX2 (0.41) NPC1MEN1KMT2APOLBMAPT
SCHEMBL22150392 0.83 EPHX2 (0.41) NPC1MEN1KMT2APOLBMAPT
SCHEMBL24614018 0.83 SMN1; SMN2 (0.44) NPC1MEN1KMT2APOLBTACR3
SCHEMBL25468526 0.81 HSD17B10 (0.38) NPC1MEN1KMT2ATACR3ALDH1A1
SCHEMBL26375593 0.80 NPC1 (0.49) NPC1MEN1KMT2APOLBMAPT
SCHEMBL17522138 0.80 PIK3CD (0.43) NPC1MEN1KMT2APOLBALDH1A1
SCHEMBL17522199 0.80 PIK3CD (0.43) NPC1MEN1KMT2APOLBALDH1A1
SCHEMBL17522201 0.80 PIK3CD (0.43) NPC1MEN1KMT2APOLBALDH1A1
SCHEMBL24614016 0.79 FAAH (0.40) NPC1TACR3ALDH1A1LMNADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018102419-A1 COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS Epizyme, Inc. (US) 2018-06-07 WO disclosed